Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$510.4M-1.0%$532.2M+16.9%$491.5M+19.3%$534.2M+54.3%$515.3M+48.7%
$153.2M-4.1%$157.6M-4.8%$154.7M-6.2%$163.2M-3.3%$159.8M-0.9%
-$285.8M-150%-$189.7M-18.4%-$186M-223%-$198.7M-1,657%-$114.2M-340%
$241.4M-19.7%$295.5M+45.1%$295.5M-26.8%$340M+4.0%$300.8M-30.6%
$500K+66.7%$500K+25.0%$300K-45.6%$400K-29.7%$300K-48.7%
-$232.8M+26.4%-$286.5M-30.9%-$312.7M+20.5%-$356.2M-10.0%-$316.5M+26.4%
-$14.1M$42.4M-$14M-$36M
$357.2M+0.5%$374.6M+29.4%$336.8M+36.3%$371M+109%$355.5M+91.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Bio-Rad Laboratories, Inc. generate?
Bio-Rad Laboratories, Inc. (BIO.B) generated $510.4M in operating cash flow over the trailing twelve months.
What is Bio-Rad Laboratories, Inc.'s free cash flow?
After $153.2M of capital expenditures, Bio-Rad Laboratories, Inc.'s free cash flow was $357.2M over the trailing twelve months, up 0.5% year over year.
Where does Bio-Rad Laboratories, Inc.'s cash flow data come from?
Every line is extracted from Bio-Rad Laboratories, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.